AMA Ed Hub Logo

Learn more on prescription drugs from AMA Ed Hub™
Red JAMA Logo

Learn more on prescription drugs from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on prescription drugs from PolicyFinder
United States Adopted Names Council

United States Adopted Names (USAN)
Clear Search
·
5 Min Read

Jan. 9, 2026: National Advocacy Update

Telehealth flexibilities for prescribing controlled substances extended and more in the latest National Advocacy Update.

Advocacy Update

Your powerful ally

The AMA helps physicians build a better future for medicine, advocating in the courts and on the Hill to remove obstacles to patient care and confront today’s greatest health crises.

Join the AMA
Physician or health care professional reviewing patient lab results on a computer desktop
UPDATED
·
3 Min Read

Addressing and managing drug shortages

The AMA has declared drug shortages to be an urgent public health crisis. Stay informed and access resources to address the impacts on practice.

Federal Advocacy
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Dec. 22, 2025

In the news: Similar genetics may drive multiple psychiatric conditions, FDA approves oral semaglutide pill, COVID-19 may have link to chronic conditions and more.

Publications & Newsletters
UPDATED
·
2 Min Read

Consumer-driven health care: Council on Medical Service reports

Download PDFs of key council reports that advance policies that emphasize patient choice and control of their health care by addressing high-value care, retail/store-based clinics, addiction treatment centers, genetic/genomic precision medicine, telemedicine, insurance coverage options, reference pricing, prescription drugs, and hospital care coordination.

Medical Service
UPDATED
·
2 Min Read

Drug coverage & spending: Council on Medical Service reports

Download PDFs of council reports that have proposed strategies to address high and escalating prescription drug prices and costs, including promoting transparency and pharmaceutical market competition, combating anti-competitive practices, and outlining criteria for value-based pricing and prescription drug importation.

Medical Service
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Oct. 27, 2025

In the news: Stillbirths more common in U.S. than previously reported, GLP-1s show promise in treating substance use disorders and more. 

Publications & Newsletters
·
6 Min Read

Oct. 31, 2025: National Advocacy Update

FDA issues new guidance aimed at speeding biosimilar time to market and lower costs, and more in the latest National Advocacy Update.

Advocacy Update
Tired man scrolls through a smartphone in a darkened bedroom
·
4 Min Read

GLP-1s and macular degeneration: Is there a link?

A JAMA Ophthalmology study of 90,000 patients examines that question. Learn more, plus see what else is trending in JAMA Network journals.

Publications & Newsletters
UPDATED
·
3 Min Read

Public health: CSAPH reports

Download PDFs of reports on this topic for the Council on Science and Public Health (CSAPH) presented during the AMA Interim and Annual Meetings.

Science & Public Health